Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
This originally appeared at https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1898878 October 2014 Marcus A. Bachhuber, MD1,2,3; Brendan Saloner, PhD3,4; Chinazo O. Cunningham, MD, MS5; et alColleen L. Barry, PhD, MPP3,6 JAMA Intern Med. 2014;174(10):1668-1673. doi:10.1001/jamainternmed.2014.4005 Abstract Importance Opioid analgesic overdose mortality continues to rise in the United States, driven by increases in prescribing for chronic pain. Because chronic pain is a major indication for medical cannabis, laws that establish access to medical cannabis may […]
The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms
This originally appeared at https://pubmed.ncbi.nlm.nih.gov/24175484/ Abstract Cannabinoids, including tetrahydrocannabinol and cannabidiol, are the most important active constituents of the cannabis plant. Over recent years, cannabinoid-based medicines (CBMs) have become increasingly available to patients in many countries, both as pharmaceutical products and as herbal cannabis (marijuana). While there seems to be a demand for multiple cannabinoid-based […]
Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
This originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/ Published online 2012 Dec 11. doi: 10.1016/j.jpain.2012.10.009 PMCID: PMC3566631 NIHMSID: NIHMS439212 PMID: 23237736 Barth Wilsey, MD, Thomas D. Marcotte, PhD, Associate Professor, Reena Deutsch, PhD, Statistician, Ben Gouaux, Research Associate, Staci Sakai, Research Associate, and Haylee Donaghe, Research Associate Abstract We conducted a double-blind, placebo-controlled, crossover study evaluating the analgesic efficacy of vaporized cannabis in subjects, the majority of whom were experiencing neuropathic pain despite […]
Medical Marijuana Laws and Suicides by Gender and Age
This originally appeared at https://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2013.301612 Published Online: November 12, 2014 Objectives. We estimated the association between legalizing medical marijuana and suicides. Methods. We obtained state-level suicide data from the National Vital Statistics System’s Mortality Detail Files for 1990–2007. We used regression analysis to examine the association between medical marijuana legalization and suicides per 100 000 population. […]
Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence
This originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753886/ Am J Addict. Author manuscript; available in PMC 2009 Sep 29. Published in final edited form as: Am J Addict. 2009 Jul–Aug; 18(4): 301–308. doi: 10.1080/10550490902927785PMCID: PMC2753886NIHMSID: NIHMS141953PMID: 19444734 Intermittent Marijuana Use Is Associated with Improved Retention in Naltrexone Treatment for Opiate-Dependence Wilfrid Noel Raby, PhD, MD, Kenneth M. Carpenter, PhD, Jami Rothenberg, PhD, Adam C. Brooks, PhD, Huiping […]
THE EFFECTS OF DRONABINOL DURING DETOXIFICATION AND THE INITIATION OF TREATMENT WITH EXTENDED RELEASE NALTREXONE
This originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536087/ Drug Alcohol Depend. 2015 Sep 1; 154: 38–45. Published online 2015 Jul 8. doi: 10.1016/j.drugalcdep.2015.05.013 PMCID: PMC4536087 NIHMSID: NIHMS706399 PMID: 26187456 Adam Bisaga,* Maria A. Sullivan, Andrew Glass, Kaitlyn Mishlen, Martina Pavlicova, Margaret Haney, Wilfrid N. Raby, Frances R. Levin, Kenneth M. Carpenter, John J. Mariani, and Edward V. Nunes Abstract Background Evidence suggests that the cannabinoid system is involved in the maintenance of opioid […]
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors
This article originally appeared at https://onlinelibrary.wiley.com/doi/abs/10.1111/dar.12323 First published: 14 September 2015 Abstract Introduction and Aims Recent years have witnessed increased attention to how cannabis use impacts the use of other psychoactive substances. The present study examines the use of cannabis as a substitute for alcohol, illicit substances and prescription drugs among 473 adults who use […]
Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study
This originally appeared at https://pubmed.ncbCannabis for Parkinson diseasei.nlm.nih.gov/24614667/ Abstract Objective: The use of cannabis as a therapeutic agent for various medical conditions has been well documented. However, clinical trials in patients with Parkinson disease (PD) have yielded conflicting results. The aim of the present open-label observational study was to assess the clinical effect of cannabis […]
Cannabis as a Substitute for Alcohol: A Harm-Reduction Approach
This article originally appeared at https://hams.cc/mikuriya.pdf Author: Tod H. Mikuriya, MD, is Psychiatric Medical Consultant, Berkeley, CA, and Presi-dent, California Cannabis Research Medical Group ABSTRACT. Ninety-two Northern Californians who use cannabis as an alternative to alcohol obtained letters of approval from the author. Their records were reviewed to determine characteristics of the cohort and efficacy […]
Marijuana Could Help Reduce Depression and Anxiety
This article originally appeared at https://www.discovermagazine.com/health/tracing-the-link-between-marijuana-and-mental-health Our knowledge about (and acceptance of) cannabis has expanded rapidly in recent years. But researchers are still probing the link between weed, depression and other mental health markers. There was a panic over pot in the 1930s. When the movie Reefer Madness came out in 1936, the criminalization of marijuana was […]
